Voltaren Topical Pain Relief Gel

Voltaren gel offers targeted relief from arthritis and muscle pain, available over-the-counter for everyday use worldwide.

Voltaren gel delivers fast-acting relief from joint and muscle pain, making it a go-to option for millions seeking non-oral pain management.

Updated: 05/14/2026

By Elena Martinez, Senior Product Editor - covering consumer health products and global markets.

At a Glance

• Product: Voltaren Topical Pain Relief Gel
• Category: Topical NSAID
• Brand/Manufacturer: Haleon
• Primary Use Cases: Arthritis pain, muscle strains, joint inflammation
• Availability: Over-the-counter in US, Europe, and select global markets
• Key Markets: North America, Europe, Asia-Pacific

What Voltaren Topical Pain Relief Gel Is and How It Works

Voltaren Topical Pain Relief Gel is a non-steroidal anti-inflammatory drug (NSAID) formulated as a clear, fragrance-free gel for direct application to painful areas. Its active ingredient, diclofenac sodium (1% concentration in the US OTC version), penetrates the skin to reduce inflammation at the source.

Users apply a dime-sized amount up to four times daily, rubbing it gently into joints or muscles. The gel absorbs quickly without greasy residue, providing relief that starts within one hour and lasts up to 12 hours per application. Clinical studies confirm it matches oral NSAID efficacy for knee osteoarthritis pain while minimizing systemic exposure.

Unlike pills, Voltaren targets pain locally, lowering risks of stomach upset or cardiovascular side effects associated with swallowed NSAIDs. It comes in easy-to-use tubes, with dosing cards ensuring precise application.

Why Voltaren Topical Pain Relief Gel Matters for Consumers and Industry

For consumers, Voltaren represents accessible self-care for chronic conditions like osteoarthritis affecting over 32 million US adults. Its OTC status since 2020 empowers users to manage pain without prescriptions, prescriptions, supporting active lifestyles from sports recovery to daily mobility.

In the $75 billion global pain relief market, Voltaren stands out as the #1 doctor-recommended topical NSAID brand. It appeals to those avoiding opioids or oral meds, aligning with trends toward non-invasive therapies amid rising awareness of NSAID risks.

Industry-wide, its success drives innovation in transdermal delivery, influencing formulations from competitors like Aspercreme and Biofreeze. Haleon leverages Voltaren's brand strength to expand into gels, patches, and creams, capturing share in aging populations worldwide.

Voltaren Topical Pain Relief Gel in the Global Market

Voltaren leads topical pain relief sales, with strong demand in the US post-FDA OTC switch. Europe has long embraced it, while Asia-Pacific growth accelerates via e-commerce and pharmacy chains.

Competition includes generic diclofenac gels and menthol-based alternatives, but Voltaren's clinical backing and marketing maintain premium positioning. Supply chains rely on stable API production, unaffected by recent disruptions.

Regulatory approvals span FDA, EMA, and counterparts, ensuring consistent quality. Adoption surges among athletes and seniors, with digital campaigns boosting awareness.

Voltaren Topical Pain Relief Gel is produced by Haleon, a consumer health leader spun off from GSK in 2022. The brand operates independently with dedicated manufacturing and R&D.

Haleon trades on the London Stock Exchange under ISIN GB0009252882, reflecting its focus on everyday health brands like Voltaren.

Disclaimer: This article is not investment advice. Stocks are volatile financial instruments.